Best Practices with Coronary IVL: Nodular & Eccentric Calcium
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker's Bureau - AstraZenca; Amgen; Abiomed; Boston Scientific Corporation; Cardiovascular Systems Inc
- Grant Support/Research Contract - Abbott Vascular
- Equity/Stock(s)/Options - Shockwave